by Jason Heaviland | Jul 16, 2026
How are exposure patterns linked to biological pathways? Environmental chemical exposures can significantly influence drug metabolism, therapeutic response, and disease biology—but they are often overlooked in biomedical research and clinical development.In this...
by Jason Heaviland | Jul 8, 2026
Untargeted Metabolomic and Lipidomic Profiling as a Supplemental Assay for Diagnosis of Periodontitis July 28, 2026 | 12:00 PM ET Traditional methods for diagnosing periodontitis rely on clinical examinations and radiographic imaging, but these approaches may not...
by Jason Heaviland | Jun 24, 2026
How Exposomics Is Measured: Sample Types, Sensitivity, and Workflows How are exposomics measurements performed, what sample types can be analyzed, and how sensitive are modern exposomics assays? In this episode of ChatGJP, Panome Bio VP of Operations Adam Richardson...
by Jason Heaviland | Jun 12, 2026
ChatGJP: Discovery vs Targeted Exposomics Explained Should you use discovery exposomics or targeted exposomics? In this episode of ChatGJP, Panome Bio CEO Ed Weinstein explains the strengths of each approach and how they work together to provide a comprehensive...
by Jason Heaviland | Jun 2, 2026
ChatGJP: Exposomics, PFAS, and Clinical Trial Implications In this episode of ChatGJP, Panome Bio President and Co-Founder Tom Cohen explores the growing field of exposomics and its role in understanding how environmental exposures influence human health and disease....
